These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 18592373)

  • 1. Role of melatonin in the epigenetic regulation of breast cancer.
    Korkmaz A; Sanchez-Barcelo EJ; Tan DX; Reiter RJ
    Breast Cancer Res Treat; 2009 May; 115(1):13-27. PubMed ID: 18592373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circadian regulation of molecular, dietary, and metabolic signaling mechanisms of human breast cancer growth by the nocturnal melatonin signal and the consequences of its disruption by light at night.
    Blask DE; Hill SM; Dauchy RT; Xiang S; Yuan L; Duplessis T; Mao L; Dauchy E; Sauer LA
    J Pineal Res; 2011 Oct; 51(3):259-69. PubMed ID: 21605163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melatonin suppresses aromatase expression and activity in breast cancer associated fibroblasts.
    Knower KC; To SQ; Takagi K; Miki Y; Sasano H; Simpson ER; Clyne CD
    Breast Cancer Res Treat; 2012 Apr; 132(2):765-71. PubMed ID: 22237979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanisms of melatonin anticancer effects.
    Hill SM; Frasch T; Xiang S; Yuan L; Duplessis T; Mao L
    Integr Cancer Ther; 2009 Dec; 8(4):337-46. PubMed ID: 20050373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic mechanisms regulating CYP19 transcription in human breast adipose fibroblasts.
    Knower KC; To SQ; Simpson ER; Clyne CD
    Mol Cell Endocrinol; 2010 Jun; 321(2):123-30. PubMed ID: 20211687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen-signaling pathway: a link between breast cancer and melatonin oncostatic actions.
    Cos S; González A; Martínez-Campa C; Mediavilla MD; Alonso-González C; Sánchez-Barceló EJ
    Cancer Detect Prev; 2006; 30(2):118-28. PubMed ID: 16647824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melatonin modulates aromatase activity and expression in endothelial cells.
    Alvarez-García V; González A; Martínez-Campa C; Alonso-González C; Cos S
    Oncol Rep; 2013 May; 29(5):2058-64. PubMed ID: 23450505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melatonin and cancer suppression: insights into its effects on DNA methylation.
    Davoodvandi A; Nikfar B; Reiter RJ; Asemi Z
    Cell Mol Biol Lett; 2022 Sep; 27(1):73. PubMed ID: 36064311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melatonin: an inhibitor of breast cancer.
    Hill SM; Belancio VP; Dauchy RT; Xiang S; Brimer S; Mao L; Hauch A; Lundberg PW; Summers W; Yuan L; Frasch T; Blask DE
    Endocr Relat Cancer; 2015 Jun; 22(3):R183-204. PubMed ID: 25876649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melatonin and associated signaling pathways that control normal breast epithelium and breast cancer.
    Hill SM; Blask DE; Xiang S; Yuan L; Mao L; Dauchy RT; Dauchy EM; Frasch T; Duplesis T
    J Mammary Gland Biol Neoplasia; 2011 Sep; 16(3):235-45. PubMed ID: 21773809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doxorubicin resistance in breast cancer is driven by light at night-induced disruption of the circadian melatonin signal.
    Xiang S; Dauchy RT; Hauch A; Mao L; Yuan L; Wren MA; Belancio VP; Mondal D; Frasch T; Blask DE; Hill SM
    J Pineal Res; 2015 Aug; 59(1):60-9. PubMed ID: 25857269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide profiling in melatonin-exposed human breast cancer cell lines identifies differentially methylated genes involved in the anticancer effect of melatonin.
    Lee SE; Kim SJ; Yoon HJ; Yu SY; Yang H; Jeong SI; Hwang SY; Park CS; Park YS
    J Pineal Res; 2013 Jan; 54(1):80-8. PubMed ID: 22856590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic inhibition of the tumor suppressor ARHI by light at night-induced circadian melatonin disruption mediates STAT3-driven paclitaxel resistance in breast cancer.
    Xiang S; Dauchy RT; Hoffman AE; Pointer D; Frasch T; Blask DE; Hill SM
    J Pineal Res; 2019 Sep; 67(2):e12586. PubMed ID: 31077613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circadian stage-dependent inhibition of human breast cancer metabolism and growth by the nocturnal melatonin signal: consequences of its disruption by light at night in rats and women.
    Blask DE; Dauchy RT; Brainard GC; Hanifin JP
    Integr Cancer Ther; 2009 Dec; 8(4):347-53. PubMed ID: 20042410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melatonin as a selective estrogen enzyme modulator.
    Cos S; González A; Martínez-Campa C; Mediavilla MD; Alonso-González C; Sánchez-Barceló EJ
    Curr Cancer Drug Targets; 2008 Dec; 8(8):691-702. PubMed ID: 19075592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer therapy based on melatonin.
    Sanchez-Barcelo EJ; Mediavilla MD; Alonso-Gonzalez C; Rueda N
    Recent Pat Endocr Metab Immune Drug Discov; 2012 May; 6(2):108-16. PubMed ID: 22369716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melatonin modulates aromatase activity in MCF-7 human breast cancer cells.
    Cos S; Martínez-Campa C; Mediavilla MD; Sánchez-Barceló EJ
    J Pineal Res; 2005 Mar; 38(2):136-42. PubMed ID: 15683469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melatonin receptors, melatonin metabolizing enzymes and cyclin D1 in human breast cancer.
    Rögelsperger O; Wlcek K; Ekmekcioglu C; Humpeler S; Svoboda M; Königsberg R; Klimpfinger M; Jäger W; Thalhammer T
    J Recept Signal Transduct Res; 2011 Apr; 31(2):180-7. PubMed ID: 21385053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membrane-bound melatonin receptor MT1 down-regulates estrogen responsive genes in breast cancer cells.
    Girgert R; Hanf V; Emons G; Gründker C
    J Pineal Res; 2009 Aug; 47(1):23-31. PubMed ID: 19522736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen Receptor-β Modulation of the ERα-p53 Loop Regulating Gene Expression, Proliferation, and Apoptosis in Breast Cancer.
    Lu W; Katzenellenbogen BS
    Horm Cancer; 2017 Aug; 8(4):230-242. PubMed ID: 28577282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.